These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


135 related items for PubMed ID: 3906119

  • 1. Practical applications of a monoclonal antibody (NDOG2) against placental alkaline phosphatase in ovarian cancer.
    Davies JO, Davies ER, Howe K, Jackson P, Pitcher E, Randle B, Sadowski C, Stirrat GM, Sunderland CA.
    J R Soc Med; 1985 Nov; 78(11):899-905. PubMed ID: 3906119
    [Abstract] [Full Text] [Related]

  • 2. Radionuclide imaging of ovarian tumours with 123I-labelled monoclonal antibody (NDOG2) directed against placental alkaline phosphatase.
    Davies JO, Davies ER, Howe K, Jackson PC, Pitcher EM, Sadowski CS, Stirrat GM, Sunderland CA.
    Br J Obstet Gynaecol; 1985 Mar; 92(3):277-86. PubMed ID: 3978058
    [Abstract] [Full Text] [Related]

  • 3. Detection of placental-type alkaline phosphatase in ovarian cancer.
    McDicken IW, McLaughlin PJ, Tromans PM, Luesley DM, Johnson PM.
    Br J Cancer; 1985 Jul; 52(1):59-64. PubMed ID: 3893506
    [Abstract] [Full Text] [Related]

  • 4. Targeting of tumours with murine and reshaped human monoclonal antibodies against placental alkaline phosphatase: immunolocalisation, pharmacokinetics and immune response.
    Kalofonos HP, Kosmas C, Hird V, Snook DE, Epenetos AA.
    Eur J Cancer; 1994 Jul; 30A(12):1842-50. PubMed ID: 7880616
    [Abstract] [Full Text] [Related]

  • 5. Immunohistology of normal and ovarian cancer tissue with a monoclonal antibody to placental alkaline phosphatase.
    Sunderland CA, Davies JO, Stirrat GM.
    Cancer Res; 1984 Oct; 44(10):4496-502. PubMed ID: 6467208
    [Abstract] [Full Text] [Related]

  • 6. Antibody-guided radiolocalisation of tumours in patients with testicular or ovarian cancer using two radioiodinated monoclonal antibodies to placental alkaline phosphatase.
    Epenetos AA, Carr D, Johnson PM, Bodmer WF, Lavender JP.
    Br J Radiol; 1986 Feb; 59(698):117-25. PubMed ID: 3947819
    [Abstract] [Full Text] [Related]

  • 7. Radionuclide imaging of epithelial ovarian tumours with 123I-labelled monoclonal antibody (H317) specific for placental-type alkaline phosphatase.
    Critchley M, Brownless S, Patten M, McLaughlin PJ, Tromans PM, McDicken IW, Johnson PM.
    Clin Radiol; 1986 Mar; 37(2):107-12. PubMed ID: 3698490
    [Abstract] [Full Text] [Related]

  • 8. Tumour-associated monoclonal antibodies for the diagnosis and assessment of ovarian cancer.
    Shepherd JH, Granowska M, Britton KE, Mather S, Epenetos AA, Ward BG, Slevin M.
    Br J Obstet Gynaecol; 1987 Feb; 94(2):160-7. PubMed ID: 3828255
    [Abstract] [Full Text] [Related]

  • 9. Radionuclide imaging of ovarian tumours with a radiolabelled (123I) monoclonal antibody (NDOG2).
    Jackson PC, Pitcher EM, Davies JO, Davies ER, Sadowski CS, Staddon GE, Stirrat GM, Sunderland CA.
    Eur J Nucl Med; 1985 Feb; 11(1):22-8. PubMed ID: 4043110
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The expression of placental alkaline phosphatase (PLAP) and PLAP-like enzymes in normal and neoplastic human tissues. An immunohistological survey using monoclonal antibodies.
    Hamilton-Dutoit SJ, Lou H, Pallesen G.
    APMIS; 1990 Sep; 98(9):797-811. PubMed ID: 2171580
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diagnosis of ovarian cancer with radiolabelled monoclonal antibodies: our experience using 131I-B72.3.
    Mansi L, Panza N, Lastoria S, Pacilio G, Salvatore M.
    Int J Rad Appl Instrum B; 1989 Sep; 16(2):127-35. PubMed ID: 2715006
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cells.
    de Kretser TA, Thorne HJ, Jacobs DJ, Jose DG.
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1019-35. PubMed ID: 2998800
    [Abstract] [Full Text] [Related]

  • 16. Serum placental alkaline phosphatase (PLAP) in gynecologic malignancies--with special reference to the combination of PLAP and CA54/61 assay.
    Nozawa S, Udagawa Y, Ohkura H, Negishi Y, Akiya K, Inaba N, Takamizawa H, Kimura E, Terashima Y.
    Clin Chim Acta; 1990 Jan 15; 186(2):275-84. PubMed ID: 2178810
    [Abstract] [Full Text] [Related]

  • 17. Serum placental-like alkaline phosphatase (PLAP): a novel combined enzyme linked immunoassay for monitoring ovarian cancer.
    Fisken J, Leonard RC, Shaw G, Bowman A, Roulston JE.
    J Clin Pathol; 1989 Jan 15; 42(1):40-5. PubMed ID: 2921344
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibody targeting of ovarian carcinoma.
    Kosmas C, Kalofonos HP, Hird V, Epenetos AA.
    Oncology; 1998 Jan 15; 55(5):435-46. PubMed ID: 9732222
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of placental alkaline phosphatase in epithelial ovarian tumours.
    Stendahl U, Lindgren A, Tholander B, Makyia R, Stigbrand T.
    Tumour Biol; 1989 Jan 15; 10(3):126-32. PubMed ID: 2762736
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.